Official UK procurement notice
Fortress Diagnostics COVID-19 Antibody Test Kits
Authority: Department of Health & Social Care (Central government)
What is being bought
Published requirement descriptionProvision of Lateral Flow Devices for Covid-19 Testing
CPV: Diagnostic kits
The lotProcurement structure
single lot · no lot value publishedLot #1Awarded
Procedure terms & legal framework
From the official record- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 11 Feb 2021, 18:02 GMT
- Last source update
- 11 Feb 2021, 18:02 GMT
- FTS notice number
2021/S 000-002841- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-029280Find a Tender
- Why no open competition
The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons
- Published justification
Negotiated Procedure Without Prior Publication. 1. On 11 March 2020 the World Health Organisation declared a COVID-19 pandemic with the associated serious risk posed to life. 2. As part of those arrangements, it needs to acquire product in order to implement the large-scale antibody testing programme necessary to build a profile of the spread of COVID-19 and to prevent further loss of human life, to allow the population to return to work safely. Relevant to its procurement strategy is the efficient use of the capacity of the test instruments it already has installed at laboratories throughout the UK.3. DHSC is satisfied the tests permitting use of the Negotiated procedure without prior publication (Regulation 32(2)(b)(ii)) are met:A. The works, supplies or services can be supplied only by a particular economic operator as competition is absent for technical reasons: Fortress device is the only approved device and Una Health is the UK Exclusive distributor.B. No reasonable alternative or substitute exists – The Fortress device is the only lateral flow antibody device approved for use outside a clinical setting by the MHRA.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Una Health LtdSME | £750,000 † | — | Awarded |
Contracts
Contract 002841-2021-1 · Una Health LtdSME
- Signed
- 12 Jan 2021
- Value
- £750,000
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- The High CourtReview body
Bidders & participating suppliers
1 commercial party on the notice- Una Health LimitedAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.